Clarius Group LLC Grows Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Clarius Group LLC grew its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 10.4% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 878 shares of the medical equipment provider’s stock after acquiring an additional 83 shares during the quarter. Clarius Group LLC’s holdings in Intuitive Surgical were worth $500,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. TRUE Private Wealth Advisors grew its stake in Intuitive Surgical by 7.0% during the 2nd quarter. TRUE Private Wealth Advisors now owns 367 shares of the medical equipment provider’s stock worth $209,000 after buying an additional 24 shares during the last quarter. Renaissance Investment Group LLC grew its stake in Intuitive Surgical by 2.7% during the 2nd quarter. Renaissance Investment Group LLC now owns 8,434 shares of the medical equipment provider’s stock worth $4,806,000 after buying an additional 222 shares during the last quarter. Paragon Advisors LLC grew its stake in Intuitive Surgical by 56.9% during the 2nd quarter. Paragon Advisors LLC now owns 1,345 shares of the medical equipment provider’s stock worth $766,000 after buying an additional 488 shares during the last quarter. Spence Asset Management grew its stake in Intuitive Surgical by 2.6% during the 2nd quarter. Spence Asset Management now owns 24,023 shares of the medical equipment provider’s stock worth $13,689,000 after buying an additional 610 shares during the last quarter. Finally, Burns J W & Co. Inc. NY grew its stake in Intuitive Surgical by 6.6% during the 2nd quarter. Burns J W & Co. Inc. NY now owns 1,536 shares of the medical equipment provider’s stock worth $875,000 after buying an additional 95 shares during the last quarter. Institutional investors and hedge funds own 87.29% of the company’s stock.

In other news, SVP Jamie Samath sold 248 shares of the stock in a transaction on Tuesday, April 21st. The stock was sold at an average price of $506.18, for a total transaction of $125,532.64. Following the completion of the sale, the senior vice president now owns 385 shares in the company, valued at approximately $194,879.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP David J. Rosa sold 17,950 shares of the stock in a transaction on Monday, June 15th. The shares were sold at an average price of $553.49, for a total value of $9,935,145.50. Following the sale, the executive vice president now owns 37,269 shares of the company’s stock, valued at approximately $20,628,018.81. The disclosure for this sale can be found here. Insiders sold 34,223 shares of company stock valued at $18,611,408 over the last 90 days. 1.60% of the stock is currently owned by insiders.

A number of research analysts recently issued reports on the company. Canaccord Genuity dropped their price target on Intuitive Surgical from $655.00 to $562.00 and set a “buy” rating on the stock in a research note on Friday, April 17th. Wells Fargo & Co boosted their price target on Intuitive Surgical from $561.00 to $632.00 and gave the stock an “overweight” rating in a research note on Thursday, June 4th. Morgan Stanley lowered their price objective on Intuitive Surgical from $670.00 to $622.00 and set an “overweight” rating for the company in a report on Friday, March 27th. Deutsche Bank lowered their price objective on Intuitive Surgical from $595.00 to $500.00 and set a “hold” rating for the company in a report on Friday, April 17th. Finally, ValuEngine raised Intuitive Surgical from a “sell” rating to a “hold” rating in a report on Friday, March 13th. Four investment analysts have rated the stock with a sell rating, seven have issued a hold rating, thirteen have given a buy rating and one has assigned a strong buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $577.83.

Shares of ISRG stock opened at $580.96 on Thursday. Intuitive Surgical, Inc. has a 12-month low of $360.50 and a 12-month high of $619.00. The firm has a market capitalization of $67.09 billion, a price-to-earnings ratio of 50.04, a price-to-earnings-growth ratio of 13.02 and a beta of 0.93. The business has a 50 day simple moving average of $571.34 and a 200 day simple moving average of $549.73.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, April 16th. The medical equipment provider reported $2.69 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.54 by $0.15. Intuitive Surgical had a return on equity of 17.40% and a net margin of 30.11%. The business had revenue of $1.10 billion during the quarter, compared to analyst estimates of $1.01 billion. During the same period in the prior year, the company posted $2.61 EPS. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. On average, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.78 EPS for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories. Its da Vinci Surgical System transforms the surgeon's natural hand movements outside the body into corresponding micro-movements inside the patient's body. The company's da Vinci Surgical System include surgeon's consoles, patient-side carts, 3-D vision systems, da Vinci skills simulators, da Vinci Xi integrated table motions, and Firefly fluorescence imaging products that enable surgeons to perform various surgical procedures, including gynecologic, urologic, general, cardiothoracic, and head and neck surgical procedures.

Featured Article: Municipal Bonds

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.